<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230316057733N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-08-18</date_registration>
      <primary_sponsor>Larestan University of Medical Sciences</primary_sponsor>
      <public_title>Effect of balanced low calorie diet on depression score</public_title>
      <acronym></acronym>
      <scientific_title>The effect of a balanced low-calorie diet on depression score evaluated by Beck questionnaire in overweight and obese patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-08-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>78</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/69202</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Supportive.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Overweight and Obesity.</hc_freetext>
      <i_freetext>The current study is a 12-week randomized clinical trial with the overall goal of determining the effects of a low-calorie balanced diet on depression score based on Beck's standard questionnaire, anthropometry and body composition in overweight and obese patients. The patients will be recruited among the outpatients living in Lar city with overweight and obesity (BMI≥27) referring to Nutrition and Diet therapy Center of Larestan University of Medical Sciences with easy non-probability sampling method and based on the inclusion criteria. Written informed consent forms for participation in the trial will be obtained from all participants. The patients will be provided with a balanced weight loss diet based on individual indicators (height, weight, gender and physical activity level) and Harris-Benedict equation by subtracting 500 kcal/day from their estimated energy requirements for weight maintenance. Moreover, the participants will be asked to complete a study questionnaire, which included questions regarding their demographic and socioeconomic characteristics (age, sex, occupation, education level, marital status, and family history of Diabetes Mellitus(DM), Hypertension(HTN) and Cardio Vascular Diseases(CVD))  The participants will be also asked not to change their physical activity levels, and avoid starting to take any medicine or nutritional supplement or changing their food habits during the follow-up period. Patients following up in order to check them in terms of adherence to the diet, answering their questions and preventing samples from falling will be also done every week by phone and also by visiting patients once every two weeks. Also, to check the state of mood of the participants in the study, Beck's standard depression questionnaire will be used at the beginning and end of the intervention. Weight, height, and waist and hip circumferences (WC; HC) of subjects will be measured based upon standard protocol at the time they will be enrolled in the study (to the nearest 0.1 Kg and 0.5 cm for weight, height, WC and HC respectively). Both WC and HC were measured using a flexible non-elastic tape above the iliac crests and at the maximal buttocks, respectively. Body mass index (BMI), defined as weight (kg) divided by square of height (m2), was then calculated from these measures. Moreover, the indicators related to body composition (body fat mass) are calculated using the following formula: Body fat%: (1.2×BMI) + (0.23×age)- (10.8× g)                                 g = 0 for women                                                                                              g= 1 for men.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is No plan to release it</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Somayeh Yousai</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Larestan University Of Medical Sciences,behind the Larestan Grand Market,Karmand St,North Ghadir Blvd,Shahr_eJadid,Larestan,Fars,Iran.</address>
        <city>Larestan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7153675541</zip>
        <telephone>+98 71 5225 5512</telephone>
        <email>s_yousai@yahoo.com</email>
        <affiliation>Larestan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Somayeh Yousai</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Larestan University Of Medical Sciences,behind the Larestan Grand Market,Karmand St,North Ghadir Blvd,Shahr_eJadid,Larestan,Fars,Iran.</address>
        <city>larestan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7153675541</zip>
        <telephone>+98 71 5225 5512</telephone>
        <email>s_yousai@yahoo.com</email>
        <affiliation>Larestan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 20-60 years
BMI&gt;27
Depression score evaluated by Beck questionnaire&gt;13
Willingness to participate in the study</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnancy and Lactation
Taking anti depressant drugs
Taking multi vitamins and minerals
Having any severe systemic disease, endocrine or metabolic disorders
Having been on a weight loss diet for the past 6 months
Professional athlete</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E66.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Obesity, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The current study is a 12-week randomized clinical trial with the overall goal of determining the effects of a low-calorie balanced diet on depression score based on Beck's standard questionnaire, anthropometry and body composition in overweight and obese patients. The patients will be recruited among the outpatients living in Lar city with overweight and obesity (BMI≥27) referring to Nutrition and Diet therapy Center of Larestan University of Medical Sciences with easy non-probability sampling method and based on the inclusion criteria. Written informed consent forms for participation in the trial will be obtained from all participants. The patients will be provided with a balanced weight loss diet based on individual indicators (height, weight, gender and physical activity level) and Harris-Benedict equation by subtracting 500 kcal/day from their estimated energy requirements for weight maintenance. Moreover, the participants will be asked to complete a study questionnaire, which included questions regarding their demographic and socioeconomic characteristics (age, sex, occupation, education level, marital status, and family history of Diabetes Mellitus(DM), Hypertension(HTN) and Cardio Vascular Diseases(CVD))  The participants will be also asked not to change their physical activity levels, and avoid starting to take any medicine or nutritional supplement or changing their food habits during the follow-up period. Patients following up in order to check them in terms of adherence to the diet, answering their questions and preventing samples from falling will be also done every week by phone and also by visiting patients once every two weeks. Also, to check the state of mood of the participants in the study, Beck's standard depression questionnaire will be used at the beginning and end of the intervention. Weight, height, and waist and hip circumferences (WC; HC) of subjects will be measured based upon standard protocol at the time they will be enrolled in the study (to the nearest 0.1 Kg and 0.5 cm for weight, height, WC and HC respectively). Both WC and HC were measured using a flexible non-elastic tape above the iliac crests and at the maximal buttocks, respectively. Body mass index (BMI), defined as weight (kg) divided by square of height (m2), was then calculated from these measures. Moreover, the indicators related to body composition (body fat mass) are calculated using the following formula: Body fat%: (1.2×BMI) + (0.23×age)- (10.8× g)                                 g = 0 for women                                                                                              g= 1 for men</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Decreasing in depression score. Timepoint: In the beginning and  the end of the study. Method of measurement: Beck questionnaire.</prim_outcome>
      <prim_outcome>Weight. Timepoint: Every 2 weeks. Method of measurement: Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Larestan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-11-07</approval_date>
        <contact_name>Ethics committee of Larestan University of Medical Sciences</contact_name>
        <contact_address>Larestan University Of Medical Sciences,behind the Larestan Grand Market,Karmand St,North Ghadir Blvd,Shahr_eJadid,Larestan,Fars,Iran. Larestan Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
